Dorzolamide Hcl/Timolol Maleat
Brand name: Dorzolamide-Timolol
Rank #325 of 500 drugs by total cost
$33.5M
Total Cost
1,096,480
Total Claims
$33.5M
Total Cost
11,925
Prescribers
$31
Cost per Claim
308,705
Beneficiaries
2,292,330
30-Day Fills
$2,805
Avg Cost/Provider
92
Avg Claims/Provider
About Dorzolamide Hcl/Timolol Maleat
Dorzolamide Hcl/Timolol Maleat (sold as Dorzolamide-Timolol) was prescribed 1,096,480 times by 11,925 Medicare Part D providers in 2023, costing the program $33.5M. At $31 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 322 | Olmesartan Medoxomil (Olmesartan Medoxomil) | $33.8M | 1,102,412 |
| 323 | Niraparib Tosylate (Zejula) | $33.7M | 2,206 |
| 324 | Tapentadol Hcl (Nucynta) | $33.6M | 29,886 |
| 325 | Dorzolamide Hcl/Timolol Maleat (Dorzolamide-Timolol) | $33.5M | 1,096,480 |
| 326 | Morphine Sulfate (Morphine Sulfate Er) | $33.2M | 1,023,056 |
| 327 | Budesonide (Budesonide Dr) | $33.1M | 120,202 |
| 328 | Mavacamten (Camzyos) | $32.8M | 3,969 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology